However, recent evidence has shown that Pros1 does bind to and activate AXL in glioma sphere cultures 113, and it modulates AXL expression in oral squamous cell carcinoma cell lines 114, suggesting that Pros1 induces receptor activity function differently in different tumor microenvironments. The gene discussed is AXL; the disease is central nervous system cancer.